SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-017234
Filing Date
2023-05-10
Accepted
2023-05-10 16:15:08
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aadi-20230331.htm   iXBRL 10-Q 1775774
2 EX-31 aadi-20230331xex31.htm EX-31 11003
3 EX-32 aadi-20230331xex32.htm EX-32 5321
  Complete submission text file 0001628280-23-017234.txt   7054669

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20230331.xsd EX-101.SCH 44841
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aadi-20230331_cal.xml EX-101.CAL 56860
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20230331_def.xml EX-101.DEF 203819
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20230331_lab.xml EX-101.LAB 569434
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20230331_pre.xml EX-101.PRE 374406
63 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20230331_htm.xml XML 1011522
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 23906551
SIC: 2834 Pharmaceutical Preparations